← All stocks

Kalaris Therapeutics, Inc.

KLRS Net buying
CIK 0001754068 #4344 in the set updated 17 Sep 2026
Bought (120 mo)
$66.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$46.38M
$238.97K on a plan · $0.00 straight out of an exercise
Sold at will
$46.14M
310 of 339 sales
Net
+$20.38M
+$20.62M against sales at will

By person

25 insiders · 349 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Jovan-Embiricos Morana
Director
$49.30M (2)
$713.82K (14)
+$48.59M
19,574,963
$94.55M
GILEAD SCIENCES, INC. entity
10% owner
$10.99M (1)
+$10.99M
16,635,286
$80.35M
+21.4%
Hallal David
Director
$8.93M (8)
−$8.93M
3,019,968
$14.59M
Brenner Malcolm
Director
$7.34M (35)
−$7.34M
263,929
$1.27M
+36.1%
Wilson John Robert
Director
$6.27M (14)
−$6.27M
11,942,863
$57.68M
+80.7%
AKKARAJU SRINIVAS
Director
$6.18M (2)
+$6.18M
19,408
$93.74K
VAN BEEK JEROEN B
Chief Commercial Officer
$51.00K (1)
$6.01M (43)
−$5.96M
333,726
$1.61M
−35.2%
Leen Ann M.
Chief Scientific Officer
$5.39M (22)
−$5.39M
4,721,302
$22.80M
+99.3%
Vera Juan
Director
$5.06M (25)
−$5.06M
2,409,928
$11.64M
+7,881%
Melian Agustin
Chief Medical Officer
$3.79M (11)
−$3.79M
453,529
$2.19M
−14.6%
Bornstein Jeffrey S
Director
$67.55K (2)
$832.12K (2)
−$764.57K
110,197
$532.25K
+264.9%
Hagen Brett R
Chief Accounting Officer
$724.91K (55)
−$724.91K
0
$0.00
Brainard Diana
Chief Executive Officer
$107.10K (1)
$676.35K (34)
−$569.25K
723,363
$3.49M
+7,353%
Miller Edward
General Counsel
$291.49K (29)
−$291.49K
578,435
$2.79M
+39.6%
Sinha Vikas
See Remarks
$232.90K (39)
−$232.90K
30,144,865
$145.60M
+128.7%
Atillasoy Ercem
See Remarks
$59.50K (1)
$116.72K (8)
−$57.22K
131,372
$634.53K
GADICKE ANSBERT
Director
30,125,933
$145.51M
+124.0%
ElevateBio, LLC entity
Director
16,674,766
$80.54M
Redmile Group, LLC entity
10% owner
823,371
$3.98M
Ferrara Napoleone
Director
504,000
$2.43M
PATEL SAMIR CHANDRAKANT
Director
352,800
$1.70M
Piccina Cintia
Chief Commercial Officer
147,000
$710.01K
Tomasello Shawn
Director
70,000
$338.10K
Adams Derek N.
Director
70,000
$338.10K
Feinsod Matthew
Chief Medical Officer
4,030
$19.46K

No percentages here. This company's share count has moved by a factor of 22.9 over the window, from 5,043,357 to 115,536,550 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 320
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 310
Transactions with no price 0
Shares from compensation/vesting 121,627,984
Sales filed before the plan box existed 217
History held since 31 Jul 2020